Arteris (AIP) Q4 2025 earnings review
Inflection Point: Revenue Accelerates and FCF Turns Positive
Arteris delivered a breakout quarter to close FY25, validating its 'system IP' thesis. Revenue growth accelerated to 30% YoY ($20.1M), driven by a 50% surge in royalties and a record backlog. Crucially, the company demonstrated operating leverage, flipping to positive Free Cash Flow ($3.0M) while maintaining 90%+ gross margins. The strategic acquisition of Cycuity (Jan 2026) and expanded NXP partnership position the company well for FY26, where guidance implies further revenue acceleration (~29% growth at midpoint).
🐂 Bull Case
For several quarters, ACV and RPO growth outpaced revenue. In Q4, Revenue growth (30%) finally converged with RPO growth (32%), confirming that the backlog is successfully converting to recognized sales.
The acquisition of Cycuity adds 'security' to Arteris' existing safety and reliability value proposition. This increases potential wallet share per SoC, particularly in high-value automotive and defense sectors.
🐻 Bear Case
The Cycuity acquisition, while strategic, introduces integration risks and potential OpEx drag in H1 2026. Non-GAAP Operating Loss guidance for 26Q1 ($2.5-$3.5M) is slightly higher than 25Q4 levels ($2.2M).
Growth is heavily indexed to AI and Automotive semi cycles. Any macroeconomic slowdown affecting end-market device shipments (specifically EVs or AI servers) directly impacts the high-margin royalty stream.
⚖️ Verdict: 🟢
Bullish. Arteris has successfully transitioned from a 'promising backlog' story to an execution story. With positive FCF, accelerating revenue, and the addition of security IP, the fundamentals are significantly stronger than a year ago.
Key Themes
RPO Breakout Confirms Demand Durability
Remaining Performance Obligations (RPO) accelerated to 32% growth YoY, reaching a record $116.8M. This is a critical metric for visibility. The continued stacking of RPO, even as revenue recognition accelerates, indicates that deal intake remains robust and is not being depleted by the higher burn rate of revenue recognition.
Major Commercial Validation (NXP)
The expanded deployment with NXP Semiconductors is a significant commercial signal. NXP is utilizing the full stack (Ncore, FlexNoC, CodaCache, Magillem) across AI-enabled automotive and industrial lines. This validates the 'system IP' strategy where customers move from single-point tools to platform adoption.
OpEx Headwinds from Acquisition
While revenue is growing, the Cycuity acquisition will pressure operating expenses in the near term. Management guided for a wider Non-GAAP operating loss range for FY26 ($5.0-$9.0M) compared to the annualized run-rate of Q4. This signals that profitability leverage may pause temporarily while integration occurs.
Royalty Ramp
Royalty revenue grew 50% YoY in Q4. This is the highest margin component of the business. As the install base of 4 billion+ shipped systems grows, this line item provides a compounding base of high-quality revenue that buffers volatility in licensing deals.
Geopolitical & Trade Risks
Management continues to flag risks related to China trade relations and tariffs. While not a primary drag in Q4, the semiconductor IP sector remains sensitive to export controls, particularly regarding advanced AI and chiplet technologies where Arteris specializes.
Other KPIs
Reversing/Positive. A major milestone. FCF margin hit 15%, swinging from negative cash flow in prior periods. FY26 guidance ($5.0 - $9.0M) suggests this profitability is sustainable and not a one-off working capital anomaly.
Accelerating. Up 28% YoY. This metric combines the stability of recurring licenses with the upside of royalties. The acceleration from +24% in Q3 to +28% in Q4 indicates strong deal closure at year-end.
Stable. Continues to hover in the 90-92% range, underscoring the pure-play IP software nature of the business model. This high margin profile means incremental revenue drops quickly to the bottom line once OpEx is covered.
Guidance
Accelerating. The midpoint ($91M) implies ~29% YoY growth, an acceleration from the 22% growth achieved in FY25 ($70.6M). This suggests management sees the Cycuity contribution and organic growth compounding.
Accelerating. Represents a continued expansion of cash generation compared to FY25 ($5.3M). The midpoint ($7M) implies healthy cash conversion despite acquisition integration costs.
Stable/Sequential Growth. Midpoint ($21M) implies ~4.5% sequential growth from the strong Q4, and ~27% YoY growth vs 25Q1. This indicates no 'hangover' after a strong Q4 close.
Key Questions
Cycuity Financial Impact
What is the specific revenue contribution expected from Cycuity in FY26, and how much of the projected OpEx increase is solely attributable to this integration versus organic headcount growth?
Royalty Visibility
With royalties growing 50% YoY, is this driven by unit volume increases in existing customers or new programs coming online? How should we model royalty seasonality in FY26?
AI Revenue Mix
Can you update the percentage of new design starts or ACV that is specifically driven by AI/ML workloads versus traditional automotive/industrial applications?